Evaluate the effect of the metranidazole gel on healing of partial thickness flap in rats (serum TNF-a)
DOI:
https://doi.org/10.32828/mdj.v16i1.1031Keywords:
Metronidazole gel, Chlorhexidine gel, Cytokines, Tumor necrosis factor-alpha (TNF-a)Abstract
Background: Metronidazole is a broad-spectrum antimicrobial activity against protozoan infections and anaerobic bacteria. In the late 1950s, Metronidazole was first introduced for the treatment of trichomoniasis. At present, the antimicrobial metronidazole is one of the most widely used as antibacterial compounds in the treatment of periodontal disease 9. Beside the periodontal pocket debridement (subgingival scaling and curettage), topical application of metronidazole seems to be very efficacious. Metronidazole efficiently inhibited anaerobic microorganisms in the periodontal pockets 10.
Objective: Evaluating the effect of metronidazole gel into surgically healing process of the partial thickness flap, throughout immunological study and comparing it with the chlorhexidine gel
Animals and methods: The present study was carried out in Hawler Medical University, Medical research center, College of Dentistry
Chemicals and Reagents:- (Rat TNF-a ELISA) kit for estimation of serum tumor necrosis factor (TNF-a), KOMA BIOTECH INC. USA)
References
- Santos MJ, Vianna LAC, Gamba MA (2007). Avaliação da eficácia da pomada de própolis em portadores de feridas crônicas. Acta Paul Enferm; 20(2): 199-204.
- Ereno D. Curativo de Borracha (2003). Revista Pesquisa Fapesp [serial on the Internet]. [cited 2009 Apr 26] jun.
- Mandelbaun SH, Di Santis EP, Mandelbaun MHS. (2003) Cicatrização: conceitos atuais e recursos auxiliares. An Bras Dermatol; 78(4): 393-410.
- Ashford R, Plant G, Maher J, Teare L.(1984);Double-blind trial of metronidazole in malodorous ulcerating tumours. Lancet. 1(8388):1232-3.
- Poletti NAA, Caliri MHL, Simão CDST, Juliani KB, Tácito VE. (2002).Feridas malignas: uma revisão de literatura. Rev Bras Cancerol; 48(3):411-7.
- Kalinski C, Schnepf M, Laboy D, Hernandez L, Nusbaum J, McGrinder B, Comfort C., Alvarez OM. (2005) Effectiveness of a topical formulation containing metronidazole for wound odor and exudate control. Wounds [serial online] [cited 2005 Apr 01]; 1(4).
- Paul JC, Pieper BA (2008). Topical metronidazole for the treatment of wound odor: a review of the literature. Ostomy Wound Manage ; 54(3):18-27.
- Trindade Neto PB, Rocha KB, Lima JB, Nunes JCS, Silva ACO (2006). Rosácea granulomatosa: relato de caso - enfoque terapêutico. An Bras Dermatol; 81(5 Supl 3):S320-3.
- Sato S (2008). Metronidazole-containing Gel for the Treatment of Periodontitis: an In vivo Evaluation. Periodontics, Braz Oral Res; 22(2):145-50.
- Toskic-Radojicic M (2005).Effects of topical application of Metronidazole-containing mucoadhesive lipogel in periodontal pockets. Vojnosanit Pregl; 62(7-8):565-568.
- Tiwari G, Tiwari R, Srivastava B, Rai AK (2008).Design and evaluation of target retentive device containing metronidazole for the treatment of periodontal disease. Res J Pharm Tech. 1:390-4.
- Ramakrishnan KM, Jayaraman V, Ramachandran K, Mathivanan T (1986). The management of anaerobic infections in extensive burns. Burns; 12:270-2.
- Wachteal TL (1988). Topical antimicrobials. In: Carpajil HG, Parks DH, editors. Burns in children. Year Book Medical Publishers Inc,106-28.
- Lazar L, Monea M, Biris C (2014). Metronidazole dental gel as an adjunct to scaling and root planning: A clinical study. Acta Med Trans; 2(3):291-3
- Stoltze K (1992). Concentration of metronidazole in periodontal pockets after application of a metronidazole 25% dental gel. J Clin Periodontol 19:698-701
- Ramakrishnan KM, Jayaraman V, Ramachandran K, Mathivanan T (1986). The management of anaerobic infections in extensive burns. Burns 12:270-2.
- Rice TT (1992). Metronidazole use in malodorous skin lesions. Rehabil Nurs 17:244-5.
- Prasad D, Rao CM (1995). Wound healing profiles of ketorolac, metronidazole, and tinidazole administered postsurgically. Indian J Exp Biol; 33:845-7.
- Xie WR, Deng H, Li H, et al. (2006). Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience; 142:809–822.
- Arend WP, Dayer J-M (1995). Inhibition of the production and effects of interleukin-1 and tumour necrosis factor α in rheumatoid arthritis.Arthritis Rheum; 38: 151-160.
- Feldmann M, Brennan F, Maini RN: (1996).Role of cytokines in rheumatoid arthritis. Annu Rev Immunol.14: 397-440. 10.1146/annurev.immunol.14.1.397.
- Brennan FM, Maini RN, Feldmann M: (1998).Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol. 20:133-147
- Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN: (1992). Detection of cytokines at the cartilage-pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol., 31: 653-661.
- Krane SM:(1993). Mechanisms of tissue destruction in rheumatoid arthritis. In: Arthritis and Allied Conditions. A Textbook of Rheumatology vol 1. Edited by McCarly DJ, Koopman WJ. Philadelphi: Lea & Febiger., 763-780.
- McInnes IB, Al Mughales J, Field M: (1996).The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Med., 2: 175-182.
- McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY (1997). Interleukin-15 mediates T cell-dependent regulation of tumour necrosis factor-alpha in rheumatoid arthritis. Nature Med. 3: 189-195.
- Sebbag M, Parry SL, Brennan FM, Feldmann M: (1997). Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumour necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol. 27: 624-632
- Quirynen, M., Avontroodt, P., Peeters, W., Pauwels, M., Coucke, W. and van Steenberghe, D. (2001). Effect of different chlorhexidine formulations in mouth rinses on de novo plaque formation. Journal of Clinical Periodontology; 28:1127-1136.
- Brecx, M., Macdonald, L.L., Legary, K., Cheang, M. and Forgay, M.G (1993). Long-term effects of Meridol and chlorhexidine mouthrinses on plaque, gingivitis, staining, and bacterial vitality. Journal of Dental Research 72:1194-1197.
- Broide, D.H., Lotz, M., Cuomo, A.J., Coburn, D.A., Federman, E.C. & Wasserman, S.I. (1992). Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol., 89, 958–967.
- Mitchell, J.A., Belvisi, M.G., Akarasereenont, P., Robbins, R.A., Kwon, O.J., Croxtall, J.D., Barnes, P.J. & Vane, J.R. (1994). Induction of cyclo‐oxygenase‐2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br. J. Pharmacol., 113, 1008–1014.
- Broden EB, Sammartano RJ, Dembe C. (1985); The effect of metronidazole on wound healing in rats. Surgery; 97: 331-5.
- Kumar R, Seth RK, Sekhon MS, Bhargava JS (1995). Serum lipid peroxide and other enzyme levels of patients suffering from thermal injury. Burns; 21:96-7
- Prasad D, Rao CM (1995). Wound healing profiles of ketorolac, metronidazole and tinidazole administered post-surgically. Indian J Exp Biol 33(11):845-7.
- Rao CM, Glosh A, Raghothama C, Bairy KL(2002). Does metronidazole reduce lipid peroxidation in burn injuries to promote healing? Burns;28(5):427-9
- Rao CM, George KM, Bairy KL, Somayaji SN. (2000). An appraisal of the healing profiles of oral and external (GEL) metronidazole on partial thickness burn wounds. Indian J Pharmacol;32(5):282-7.
- Borden EB, Sammartano RJ, Dembe C, Boley SJ. (1985).The effect of metronidazole on wound healing in rats. Surgery; 97(3):331-6
- Watkins LR, Wiertelak EP, Goehler LE, et al. (1994). Characterization of cytokine-induced hyperalgesia. Brain Res; 654:15–26.
- Boka G, Anglade P, Wallach D, et al. (1994). Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neuroscience Letters; 172:151–154
- Perkins MN, Kelly D. (1994). Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology; 33:657–660.
- Woolf CJ, Allchorne A, Safieh-Garabedian B, et al. (1997). Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 121:417–424.
- Cunha FQ, Poole S, Lorenzetti BB, et al. (1992). The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol; 107:660–664.
- Creange A, Barlovatz-Meimon G, Gherardi RK. (1997). Cytokines and peripheral nerve disorders. Eur Cytokine Netw; 8:145–151
- Wagner R, Myers RR. (1996). Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport; 7:2897–2901.
- Sweitzer S, Deleo JA, Martin D (1999). Intrathecal interleukin-1 receptor antagonist and tumor necrosis factor binding protein exhibit an antiallodynic effect in a rat model of neuropathic pain. Soc Neurosci Abstr ;25 579.4
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
